Trial Profile

The Effect Of Eplerenone Versus Placebo On Cardiovascular Mortality And Heart Failure Hospitalization In Japanese Subjects With Chronic Heart Failure

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 10 Jan 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Eplerenone (Primary)
Indications Chronic heart failure
Focus Registrational; Therapeutic Use
Acronyms J-EMPHASIS-HF
Sponsors Pfizer

Most Recent Events

19 Aug 2017 Results published in the Circulation Journal
29 Dec 2016 Results of post-hoc population pharmacokinetic analysis published in the Journal of Clinical Pharmacology
05 Oct 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com